Source: Annual Congress 2012 - COPD comorbidities I
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Agapova, Y. Dolgusheva, L. Ratova, I. Chazova, K. Zykov (Moscow, Russian Federation). Phenotypic characteristics of patients with arterial hypertension and chronic obstructive pulmonary disease. Eur Respir J 2012; 40: Suppl. 56, 525

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005 Arterial stiffness in patients with chronic obstructive pulmonary disease combined with arterial hypertension Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Pulmonary hypertension associated with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006 Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002 Arterial hypertension in patients with obstructive lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 417s Year: 2003 Predictive factors of arterial stiffness in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 Genetic risks in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 454s Year: 2003 Diurnal arterial stiffness in patients with chronic obstructive pulmonary disease of varying severity Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Pulmonary haemodynamic disorders in chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Pathophysiological features of chronic obstructive pulmonary disease in obese patients Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 Endothelial dysfunction and pulmonary hypertension in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Gender-related differences in pulmonary hemodynamics in patients with end-stage COPD Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange Year: 2005 Changes of pulmonary artery distensibility in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 416s Year: 2001 Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 427s Year: 2003 Increased arterial stiffness in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 65s Year: 2006